www.fdanews.com/articles/159869-drug-pricing-challenges-diabetes-king-novo-nordisk

Drug Pricing Challenges Diabetes King Novo Nordisk

November 6, 2013

Novo Nordisk chief Lars Sorensen blames drug pricing authorities around the world for recent lags in the company’s growth.
Reuters